A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe. #lymphoma #lymsm https://t.co/w3mVip1ui2
2,454 followers
925 followers
New article: A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe. https://t.co/tdvbaSfipS #MMSM #MultipleMyeloma #hematology https://t.co/1piOKXkpz6
509 followers
RT @JournalofExper1: 🆕 A recent publication from JECCR! https://t.co/xVWlRe1ZKU 𝐃𝐂𝐙𝟑𝟑𝟎𝟏, a novel anti-tumor compound against bortezomib re…
509 followers
🆕 A recent publication from JECCR! https://t.co/xVWlRe1ZKU 𝐃𝐂𝐙𝟑𝟑𝟎𝟏, a novel anti-tumor compound against bortezomib resistance in 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐦𝐲𝐞𝐥𝐨𝐦𝐚 #MultipleMyeloma #DrugResistance #DNAdamageResponse #CellCycle Enjoy your reading ⬇️ https://t.co/kHUL34jtj